Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-004835-60Phase 4Active
Phase 4, open-label trial of hydroxocobalamin and cyanocobalamin in vitamin B12 deficiency (2 arms), sponsored by Rijnstate. Primary endpoint: Vitamin B12 status at 1 year. Started Jan 2014; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-004835-60.